Alerce Medical Technology Partners, L.P. is a private equity fund based in Chicago, Illinois. According to its most recent Form D, filed Nov 20, 2025, it has sold $195,487,844 of interests to 79 investors since its first sale in Nov 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Muneer Satter.
- Total raised
- $195,487,844Cumulative sales reported on Form D
- Investors
- 79
- First sale
- Nov 22, 2024
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Muneer Satter
- Latest Form D
- Nov 20, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Nov 20, 2025 | Form D/A (amendment) | $195,487,844 | 79 | SEC.gov ↗ |
| Nov 22, 2024 | Form D | $0 | 0 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Nov 22, 2024. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Alerce Medical Technology Partners, L.P.
What is the minimum investment for Alerce Medical Technology Partners, L.P.?
Alerce Medical Technology Partners, L.P.'s latest Form D, filed Nov 20, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Alerce Medical Technology Partners, L.P.?
Alerce Medical Technology Partners, L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has Alerce Medical Technology Partners, L.P. raised?
Alerce Medical Technology Partners, L.P. reports $195,487,844 sold from 79 investors on its Form D filed Nov 20, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Alerce Medical Technology Partners, L.P. based?
Alerce Medical Technology Partners, L.P. is based in Chicago, Illinois.
When did Alerce Medical Technology Partners, L.P. launch?
Alerce Medical Technology Partners, L.P. reports its first sale in Nov 2024.
Size compared with every private equity fund
Raised more than 76% of the 480 private equity funds based in Illinois, and more than 80% of all 9,002 that report sales.